Get started
TopgOptions

GOVX Corporate Update soon | 10X Upside Potential Analyst Rating

Long
GeoVax Labs, Inc. (NASDAQ:GOVX)  
TopgOptions  
NASDAQ:GOVX   GeoVax Labs, Inc.
Trend Analysis Technical Indicators Fundamental Analysis GOVX geovax cancer cancervaccine vaccine biotech biotechnology vaccinestocks pennystocks
8
2
trendanalysis indicator fundamental govx geovax cancer cancervaccine vaccine biotech biotechnology vaccinestocks pennystocks
GOVX GeoVax Labs is a biotechnology company developing immunotherapies and vaccines against infectious diseases and cancer.
GeoVax Labs will report Q1 2022 financial results on April 27.

Jason McCarthy from Maxim Group has a $10.00 price target for GOVX.
The stock is now $1.01.
Market Cap of only 7.23Mil.

This is a 4X upside potential short term stock in my opinion.

BUYSELL indicators tradingindicators.store/
TRADING COURSE bit.ly/tradex
Private Signals www.patreon.com/PremiumOptionsSignals
RESULTS www.bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
BYBIT partner.bybit.com/b/37880
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.